Charting New Roads
Awareness changes your destiny
Around the globe, Alzheimer’s and other types of dementia are a major challenge to the people suffering from it, their families, and the communities in which they reside. To add to the situation, there are limited remedies available to prevent and treat the dreaded disease, not to mention the underlying causes, which are debated by
According to recent research by a team of scientists based in the United Kingdom, men with the BRCA gene mutation face an increased risk of prostate cancer. For this reason, researchers are advocating prostate cancer screening for men with this particular gene defect, despite criticism of this type of cancer screening, particularly with the Prostate
Predicting Alzheimer’s Cheaply and Simply According to researchers at the University of California’s San Diego School Of Medicine and at the Washington University School of Medicine, cognitive tests may soon offer a low-cost, minimally invasive, and simple method of screening people for the genetic risk of Alzheimer’s disease. According to both recently published studies, the
Recent Study Finds BRCA1 and BRCA2 Gene Mutations to Be Particularly Dangerous A recent large study of BRCA1 and BRCA2 gene mutations found that women who have inherited these mutations are at a significantly higher risk of cancer, particularly breast and ovarian, compared to women without the mutations. Further Studies Announced An announcement was also
On behalf of the many patients who have been given a second chance, we thank you for the role you have in our international bone marrow registry. Through your involvement and support, you are a key partner in our mission of saving patients for whom a stem cell transplant is the sole chance of survival.
Dr. Talia Golan, the director of the Sheba Pancreatic Cancer Center, has made an exciting breakthrough in the search for an effective treatment for metastatic pancreatic cancer. Although years of effort and significant resources have been devoted to the illness, very few studies thus far have shown progress in finding a suitable treatment for this
Researchers recently made a significant discovery related to pancreatic cancer. When the ataxia-telangiectasia group D complementing (ATDC) gene was removed from a group of cancer-prone mice, none of the mice developed cancer. Cancer in the pancreas is a particularly deadly form of the dreaded disease. It is often diagnosed late and tends to resist treatment.